Genezen Laboratories
Genezen Laboratories is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 5 of 5 trials · Latest update first
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4)
Sponsor Kite Pharma Inc.
- Start (EU)
- Latest update
- Estimated end
Operational learnings available3 trial-level findings · Read insights
- Enrollment was geographically concentrated in the United States (66 participants), with 10 enrolled in France, 6 in Canada, 5 in Spain, 3 each in Italy and Poland, and 1 each in the Czech Republic and Germany.
- No global study interruptions or restarts were reported.
- The protocol was amended eight times during the study.
These findings describe the trial, not the service provider’s performance or responsibility.
Longterm Follow-up of Subjects with Cerebral Adrenoleukodystrophy Who Were Treated with Lenti-D Drug Product
Sponsor Genetix Biotherapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with a lentiviral vector carrying the FANCA gene (orphan drug) in patients with Fanconi Anaemia Subtype A: FANCOLEN-I
Sponsor Rocket Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Long-Term Follow-up of Subjects With Transfusion-Dependant β-Thalassemia Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Sponsor Genetix Biotherapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
A PHASE 2 MULTICENTER STUDY OF AXICABTAGENE CILOLEUCEL IN SUBJECTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA (INHL)
Sponsor Kite Pharma Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Genezen Laboratories?
The 2026-10-09 snapshot links Genezen Laboratories to 5 distinct CTIS trials. Recorded services include Laboratory services, Gene Therapy Testing, RCL testing, RCR testing by PCR, among 5 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Genezen Laboratories?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Genezen Laboratories conducted?
The linked trials record locations in 8 countries, including France, Germany, Italy, Spain, Czechia. These are trial locations, not confirmed office locations or countries where Genezen Laboratories delivered services.
What can this page tell me about Genezen Laboratories's trial experience?
Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Genezen Laboratories. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Genezen Laboratories Inc.